Loading stock data…
NMTC
$3.39-0.06 (-1.87%)
Market ClosedLast close Jun 9
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
NeuroOne Medical Technologies Corporation in the Healthcare sector is trading at $3.39 with a market capitalization of $29M. Wall Street consensus targets $9.93 (3 analysts), implying a +193.0% move over the next 12 months. The stock is currently near its 52-week low of $3.28, remaining 27.1% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 26 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +193.0% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 26) — potential for technical mean-reversion
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$3.39
Potential Downside
0%
Whystock Fair Value$3.39
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for sp...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$29.22M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.51
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-123.63%
Volume
Today's trading volume
24,383
Recent News
NeuroOne Medical Technologies Corp (NMTC) Q2 2026 Earnings Call Highlights: Strong Product ...
NeuroOne Medical Technologies Corp (NMTC) reports significant revenue growth and strategic advancements, despite facing profitability and cash flow challenges.
NeuroOne Medical Technologies Corp (NMTC) Q1 2026 Earnings Call Highlights: Navigating Revenue ...
Despite a dip in revenue, NeuroOne Medical Technologies Corp (NMTC) showcases promising advancements and strategic partnerships for future growth.
NeuroOne Medical Technologies Corporation Q1 2026 Earnings Call Summary
Moby summary of NeuroOne Medical Technologies Corporation's Q1 2026 earnings call
New Strong Buy Stocks for January 6th
ILPT, NMTC, RIGL, RIO and BHP have been added to the Zacks Rank #1 (Strong Buy) List on January 6th, 2026.
NeuroOne Medical Technologies Corp (NMTC) Q4 2025 Earnings Call Highlights: Record Revenue ...
NeuroOne Medical Technologies Corp (NMTC) reports significant revenue growth, improved margins, and strategic progress despite challenges in compliance and international expansion.